What is the share price of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) today?
The share price of LOTUSEYE as on 11th July 2025 is ₹73.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
The past returns of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share are- Past 1 week: 4.20%
- Past 1 month: 0.83%
- Past 3 months: 13.29%
- Past 6 months: 11.63%
- Past 1 year: 23.90%
- Past 3 years: 37.18%
- Past 5 years: 131.17%
What are the peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE)?
The peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE) include:What is the market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹151.92 Cr as of 11th July 2025.What is the 52 week high and low of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?
The 52-week high of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹90.98 and the 52-week low is ₹54.99.What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) stock?
The P/E (price-to-earnings) ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is 208.11. The P/B (price-to-book) ratio is 2.56.Which sector does Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belong to?
Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares?
You can directly buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Lotus Eye Hospital and Institute Ltd
LOTUSEYE Share Price
LOTUSEYE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
LOTUSEYE Performance & Key Metrics
LOTUSEYE Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
213.97 | 2.56 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.68 | 6.41 | 0.79% |
LOTUSEYE Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
LOTUSEYE Company Profile
Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.
LOTUSEYE Forecast
LOTUSEYE Forecasts
LOTUSEYE
LOTUSEYE
Income
Balance Sheet
Cash Flow
LOTUSEYE Income Statement
LOTUSEYE Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 34.67 | 38.93 | 39.11 | 41.48 | 33.20 | 39.80 | 48.19 | 49.52 | 50.87 | 50.88 | ||||||||||
Raw Materials | 10.27 | 10.89 | 6.18 | 6.11 | 4.76 | 5.69 | 6.93 | 7.05 | 46.13 | 46.14 | ||||||||||
Power & Fuel Cost | 0.98 | 1.11 | 1.24 | 1.22 | 0.96 | 0.85 | 1.03 | 1.38 | ||||||||||||
Employee Cost | 7.00 | 7.78 | 8.49 | 8.17 | 6.82 | 6.98 | 8.52 | 9.25 | ||||||||||||
Selling & Administrative Expenses | 5.52 | 6.33 | 6.38 | 6.51 | 4.06 | 5.18 | 5.96 | 6.17 | ||||||||||||
Operating & Other expenses | 6.89 | 7.56 | 12.92 | 15.29 | 12.14 | 14.29 | 16.91 | 17.73 | ||||||||||||
EBITDA | 4.01 | 5.26 | 3.90 | 4.18 | 4.46 | 6.81 | 8.84 | 7.94 | 4.74 | 4.74 | ||||||||||
Depreciation/Amortization | 3.44 | 3.37 | 3.06 | 2.50 | 2.33 | 2.50 | 2.98 | 3.73 | 3.01 | 3.02 | ||||||||||
PBIT | 0.57 | 1.89 | 0.84 | 1.68 | 2.13 | 4.31 | 5.86 | 4.21 | 1.73 | 1.72 | ||||||||||
Interest & Other Items | 0.15 | 0.18 | 0.21 | 0.24 | 0.14 | 0.21 | 0.20 | 0.20 | 0.36 | 0.36 | ||||||||||
PBT | 0.42 | 1.71 | 0.63 | 1.44 | 1.99 | 4.10 | 5.66 | 4.01 | 1.37 | 1.36 | ||||||||||
Taxes & Other Items | -0.03 | -0.04 | -0.08 | 0.39 | 0.42 | 1.11 | 1.57 | 1.10 | 0.64 | 0.65 | ||||||||||
Net Income | 0.45 | 1.75 | 0.71 | 1.05 | 1.57 | 2.99 | 4.09 | 2.91 | 0.73 | 0.71 | ||||||||||
EPS | 0.22 | 0.84 | 0.34 | 0.50 | 0.75 | 1.44 | 1.97 | 1.40 | 0.36 | 0.34 | ||||||||||
DPS | 0.50 | 0.50 | 0.00 | 0.00 | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 2.31 | 0.59 | 0.00 | 0.00 | 0.66 | 0.35 | 0.25 | 0.00 | 0.00 | 0.00 |
LOTUSEYE Company Updates
LOTUSEYE Stock Peers
LOTUSEYE Past Performance & Peer Comparison
LOTUSEYE Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Lotus Eye Hospital and Institute Ltd | 208.11 | 2.56 | — |
Max Healthcare Institute Ltd | 110.16 | 12.63 | 0.12% |
Apollo Hospitals Enterprise Ltd | 71.49 | 14.12 | 0.39% |
Fortis Healthcare Ltd | 74.55 | 6.75 | 0.13% |
LOTUSEYE Stock Price Comparison
Compare LOTUSEYE with any stock or ETFLOTUSEYE Holdings
LOTUSEYE Shareholdings
LOTUSEYE Promoter Holdings Trend
LOTUSEYE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
LOTUSEYE Institutional Holdings Trend
LOTUSEYE Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 1.77%
In last 3 months, foreign institutional holding of the company has almost stayed constant
LOTUSEYE Shareholding Pattern
LOTUSEYE Shareholding Pattern
LOTUSEYE Shareholding History
LOTUSEYE Shareholding History
smallcases containing LOTUSEYE stock
smallcases containing LOTUSEYE stock
Looks like this stock is not in any smallcase yet.
LOTUSEYE Events
LOTUSEYE Events
LOTUSEYE Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
LOTUSEYE Dividend Trend
No dividend trend available
LOTUSEYE Upcoming Dividends
LOTUSEYE Upcoming Dividends
No upcoming dividends are available
LOTUSEYE Past Dividends
LOTUSEYE Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 14, 2018
Dividend/Share
₹0.50
Ex DateEx Date
Sep 14, 2018
Cash Dividend
Ex DateEx DateAug 2, 2017
Dividend/Share
₹0.50
Ex DateEx Date
Aug 2, 2017
LOTUSEYE Stock News & Opinions
LOTUSEYE Stock News & Opinions
Net profit of Lotus Eye Hospital & Institute rose 1150.00% to Rs 0.25 crore in the quarter ended March 2025 as against Rs 0.02 crore during the previous quarter ended March 2024. Sales rose 5.79% to Rs 11.51 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024. For the full year,net profit declined 74.57% to Rs 0.74 crore in the year ended March 2025 as against Rs 2.91 crore during the previous year ended March 2024. Sales rose 2.80% to Rs 49.56 crore in the year ended March 2025 as against Rs 48.21 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales11.5110.88 6 49.5648.21 3 OPM %-1.486.89 -6.9413.54 - PBDT0.251.12 -78 4.387.73 -43 PBT0.830 0 1.374.00 -66 NP0.250.02 1150 0.742.91 -75 Powered by Capital Market - Live
Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
Country Condos Ltd, Hexa Tradex Ltd, Jagsonpal Pharmaceuticals Ltd and SEL Manufacturing Company Ltd are among the other gainers in the BSE's 'B' group today, 25 April 2025.Lotus Eye Hospital & Institute Ltd spiked 13.27% to Rs 76.75 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 22653 shares were traded on the counter so far as against the average daily volumes of 3096 shares in the past one month. Country Condos Ltd soared 9.92% to Rs 10.97. The stock was the second biggest gainer in 'B' group. On the BSE, 5.63 lakh shares were traded on the counter so far as against the average daily volumes of 1.25 lakh shares in the past one month. Hexa Tradex Ltd surged 6.95% to Rs 210.9. The stock was the third biggest gainer in 'B' group. On the BSE, 50 shares were traded on the counter so far as against the average daily volumes of 753 shares in the past one month. Jagsonpal Pharmaceuticals Ltd rose 6.69% to Rs 255.2. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1.83 lakh shares were traded on the counter so far as against the average daily volumes of 9340 shares in the past one month. SEL Manufacturing Company Ltd exploded 4.98% to Rs 42.18. The stock was the fifth biggest gainer in 'B' group. On the BSE, 17410 shares were traded on the counter so far as against the average daily volumes of 6034 shares in the past one month. Powered by Capital Market - Live
Net loss of Lotus Eye Hospital & Institute reported to Rs 0.24 crore in the quarter ended December 2024 as against net profit of Rs 0.66 crore during the previous quarter ended December 2023. Sales rose 1.83% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 12.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2512.03 2 OPM %6.4513.13 - PBDT0.881.89 -53 PBT-0.430.91 PL NP-0.240.66 PL Powered by Capital Market - Live
Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended September 2024 as against Rs 0.85 crore during the previous quarter ended September 2023. Sales rose 1.41% to Rs 12.91 crore in the quarter ended September 2024 as against Rs 12.73 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.9112.73 1 OPM %8.9114.22 - PBDT1.342.07 -35 PBT0.111.18 -91 NP0.100.85 -88 Powered by Capital Market - Live
Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended June 2024 as against Rs 1.38 crore during the previous quarter ended June 2023. Sales rose 2.55% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 12.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8912.57 3 OPM %12.9618.93 - PBDT1.922.64 -27 PBT0.861.91 -55 NP0.621.38 -55 Powered by Capital Market - Live
Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the company will be held on 13 August 2024.Powered by Capital Market - Live
BRIEF-Lotus Eye Hospital And Institute - Names Kavetha Sundaramoorthy As Chairman - Investing.com India

BRIEF-Lotus Eye Hospital And Institute Ltd - Approved Appointment Of K.S. Ramalingam As CEO - Investing.com India

Over the last 5 years, revenue has grown at a yearly rate of 4.17%, vs industry avg of 12.84%
Over the last 5 years, market share decreased from 0.1% to 0.06%
Over the last 5 years, net income has grown at a yearly rate of -7.01%, vs industry avg of 41.11%